A 3p26-3p25 genetic linkage finding for DSM-IV major depression in heavy smoking families.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 21572167.
- Also identified by DOI 10.1176/appi.ajp.2011.10091319 and PMC identifier 3433250.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors tested for genetic linkage of DSM-IV-diagnosed major depressive disorder in families that were ascertained for cigarette smoking. Within a study that targeted families characterized by a history of smoking, analyses derived a subset of 91 Australian families with two or more offspring with a history of DSM-IV major depressive disorder (affected sibling pairs, N=187) and 25 Finnish families (affected sibling pairs, N=33). Within this affected sibling pairs design, the authors conducted nonparametric linkage analysis. In the Australian heavy smoking families, the authors found a genome-wide significant multipoint LOD score of 4.14 for major depressive disorder on chromosome 3 at 24.9 cM (3p26-3p25). Genome-wide significant linkage was detected for major depressive disorder on chromosome 3p in a sample ascertained for smoking. A linkage peak at this location was also observed in an independent study of major depressive disorder.
Medical subject headings
- Alleles
- Chromosomes, Human, Pair 3
- Major Depressive Disorder
- Diagnostic and Statistical Manual of Mental Disorders
- Diseases in Twins
- Genetic Linkage
- Genome-Wide Association Study
- Receptors, Metabotropic Glutamate
- Smoking